Clinical Data Analytics Market Report by Solution (Software, Services), Deployment Mode (Cloud-Based, On-Premises), Application (Quality Improvement and Clinical Benchmarking, Clinical Decision Support, Regulatory Reporting and Compliance, Comparative Ana

Clinical Data Analytics Market Report by Solution (Software, Services), Deployment Mode (Cloud-Based, On-Premises), Application (Quality Improvement and Clinical Benchmarking, Clinical Decision Support, Regulatory Reporting and Compliance, Comparative Analytics, Precision Health), End User (Pharmaceutical Companies, Healthcare Organizations, Research Organizations, Government Organizations), and Region 2024-2032


The global clinical data analytics market size reached US$ 20.0 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 253.2 Billion by 2032, exhibiting a growth rate (CAGR) of 31.6% during 2024-2032.

Clinical data analytics transforms structured and unstructured medical data into a single, standardized ecosystem in real-time. It relies on sophisticated machine learning (ML) analysis to generate predictive and hidden insights. It assists healthcare providers in making informed decisions, providing clinical decision support, improving population health, enhancing care coordination, and improving patient wellness. As a result, it is widely adopted by health organizations across the globe to retrieve data concerning different aspects of health system performance, such as patient outcomes, population health, and clinical quality. Besides this, it can help reduce medication errors, minimize administrative costs, and increase revenues.

Clinical Data Analytics Market Trends:

The increasing usage of electronic health records (EHRs) on account of rapid digitization in healthcare management has led to vast amounts of clinical data. This represents one of the key factors driving the need for clinical data analytics to streamline information and minimize human errors. This can also be attributed to the increasing application of EHR solutions in improving patient care coordination and accessing information in real-time due to a significant impact of coronavirus disease (COVID-19) on healthcare infrastructure worldwide. Apart from this, the emergence of m-health apps, in confluence with the increasing emphasis on high-quality personalized care in hospitals, is contributing to the market growth. Moreover, several health organizations are integrating clinical data analytics to address the challenges of changing governmental regulations while lowering healthcare costs and improving the overall quality of patient care. Besides this, rising investments in clinical studies of new drugs due to the growing prevalence of chronic diseases are anticipated to positively influence the demand for clinical data analytics across the globe.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global clinical data analytics market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on solution, deployment mode, application and end user.

Breakup by Solution:
  • Software
  • Services
Breakup by Deployment Mode:
  • Cloud-based
  • On-premises
Breakup by Application:
  • Quality Improvement and Clinical Benchmarking
  • Clinical Decision Support
  • Regulatory Reporting and Compliance
  • Comparative Analytics
  • Precision Health
Breakup by End User:
  • Pharmaceutical Companies
  • Healthcare Organizations
  • Research Organizations
  • Government Organizations
Breakup by Region:
  • North America
  • United States
  • Canada
  • Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa
Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Allscripts Healthcare Solutions Inc., CareEvolution LLC, Cerner Corporation, Health Catalyst, International Business Machines Corporation, InterSystems Corporation, Koninklijke Philips N.V., Medeanalytics Inc., Sisense Inc., UnitedHealth Group Incorporated and Xerox Holdings Corporation.

Key Questions Answered in This Report

1. What was the size of the global clinical data analytics market in 2023?

2. What is the expected growth rate of the global clinical data analytics market during 2024-2032?

3. What has been the impact of COVID-19 on the global clinical data analytics market?

4. What are the key factors driving the global clinical data analytics market?

5. What is the breakup of the global clinical data analytics market based on the solution?

6. What is the breakup of the global clinical data analytics market based on the deployment mode?

7. What is the breakup of the global clinical data analytics market based on the application?

8. What is the breakup of the global clinical data analytics market based on the end user?

9. What are the key regions in the global clinical data analytics market?

10. Who are the key players/companies in the global clinical data analytics market?


1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Clinical Data Analytics Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Solution
6.1 Software
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Services
6.2.1 Market Trends
6.2.2 Market Forecast
7 Market Breakup by Deployment Mode
7.1 Cloud-based
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 On-premises
7.2.1 Market Trends
7.2.2 Market Forecast
8 Market Breakup by Application
8.1 Quality Improvement and Clinical Benchmarking
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Clinical Decision Support
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Regulatory Reporting and Compliance
8.3.1 Market Trends
8.3.2 Market Forecast
8.4 Comparative Analytics
8.4.1 Market Trends
8.4.2 Market Forecast
8.5 Precision Health
8.5.1 Market Trends
8.5.2 Market Forecast
9 Market Breakup by End User
9.1 Pharmaceutical Companies
9.1.1 Market Trends
9.1.2 Market Forecast
9.2 Healthcare Organizations
9.2.1 Market Trends
9.2.2 Market Forecast
9.3 Research Organizations
9.3.1 Market Trends
9.3.2 Market Forecast
9.4 Government Organizations
9.4.1 Market Trends
9.4.2 Market Forecast
10 Market Breakup by Region
10.1 North America
10.1.1 United States
10.1.1.1 Market Trends
10.1.1.2 Market Forecast
10.1.2 Canada
10.1.2.1 Market Trends
10.1.2.2 Market Forecast
10.2 Asia-Pacific
10.2.1 China
10.2.1.1 Market Trends
10.2.1.2 Market Forecast
10.2.2 Japan
10.2.2.1 Market Trends
10.2.2.2 Market Forecast
10.2.3 India
10.2.3.1 Market Trends
10.2.3.2 Market Forecast
10.2.4 South Korea
10.2.4.1 Market Trends
10.2.4.2 Market Forecast
10.2.5 Australia
10.2.5.1 Market Trends
10.2.5.2 Market Forecast
10.2.6 Indonesia
10.2.6.1 Market Trends
10.2.6.2 Market Forecast
10.2.7 Others
10.2.7.1 Market Trends
10.2.7.2 Market Forecast
10.3 Europe
10.3.1 Germany
10.3.1.1 Market Trends
10.3.1.2 Market Forecast
10.3.2 France
10.3.2.1 Market Trends
10.3.2.2 Market Forecast
10.3.3 United Kingdom
10.3.3.1 Market Trends
10.3.3.2 Market Forecast
10.3.4 Italy
10.3.4.1 Market Trends
10.3.4.2 Market Forecast
10.3.5 Spain
10.3.5.1 Market Trends
10.3.5.2 Market Forecast
10.3.6 Russia
10.3.6.1 Market Trends
10.3.6.2 Market Forecast
10.3.7 Others
10.3.7.1 Market Trends
10.3.7.2 Market Forecast
10.4 Latin America
10.4.1 Brazil
10.4.1.1 Market Trends
10.4.1.2 Market Forecast
10.4.2 Mexico
10.4.2.1 Market Trends
10.4.2.2 Market Forecast
10.4.3 Others
10.4.3.1 Market Trends
10.4.3.2 Market Forecast
10.5 Middle East and Africa
10.5.1 Market Trends
10.5.2 Market Breakup by Country
10.5.3 Market Forecast
11 SWOT Analysis
11.1 Overview
11.2 Strengths
11.3 Weaknesses
11.4 Opportunities
11.5 Threats
12 Value Chain Analysis
13 Porters Five Forces Analysis
13.1 Overview
13.2 Bargaining Power of Buyers
13.3 Bargaining Power of Suppliers
13.4 Degree of Competition
13.5 Threat of New Entrants
13.6 Threat of Substitutes
14 Price Analysis
15 Competitive Landscape
15.1 Market Structure
15.2 Key Players
15.3 Profiles of Key Players
15.3.1 Allscripts Healthcare Solutions Inc.
15.3.1.1 Company Overview
15.3.1.2 Product Portfolio
15.3.1.3 Financials
15.3.1.4 SWOT Analysis
15.3.2 CareEvolution LLC
15.3.2.1 Company Overview
15.3.2.2 Product Portfolio
15.3.3 Cerner Corporation
15.3.3.1 Company Overview
15.3.3.2 Product Portfolio
15.3.3.3 Financials
15.3.3.4 SWOT Analysis
15.3.4 Health Catalyst
15.3.4.1 Company Overview
15.3.4.2 Product Portfolio
15.3.4.3 Financials
15.3.5 International Business Machines Corporation
15.3.5.1 Company Overview
15.3.5.2 Product Portfolio
15.3.5.3 Financials
15.3.5.4 SWOT Analysis
15.3.6 InterSystems Corporation
15.3.6.1 Company Overview
15.3.6.2 Product Portfolio
15.3.6.3 SWOT Analysis
15.3.7 Koninklijke Philips N.V.
15.3.7.1 Company Overview
15.3.7.2 Product Portfolio
15.3.7.3 Financials
15.3.7.4 SWOT Analysis
15.3.8 Medeanalytics Inc.
15.3.8.1 Company Overview
15.3.8.2 Product Portfolio
15.3.9 Sisense Inc.
15.3.9.1 Company Overview
15.3.9.2 Product Portfolio
15.3.10 UnitedHealth Group Incorporated
15.3.10.1 Company Overview
15.3.10.2 Product Portfolio
15.3.10.3 Financials
15.3.10.4 SWOT Analysis
15.3.11 Xerox Holdings Corporation
15.3.11.1 Company Overview
15.3.11.2 Product Portfolio
15.3.11.3 Financials
15.3.11.4 SWOT Analysis

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings